Last reviewed · How we verify

NCT04017429: FURC-III-OST

Osteoplasty in Conjunction With Surgical Treatment of Mandibular Grade III Furcation Defects (FURC-III-OST)

Withdrawn NA Last updated 30 April 2021
What this trial tests

NA trial testing Open flap debridement with osteoplasty in Furcation Defects. Withdrawn.

Timeline
15 October 2019
Primary endpoint
15 June 2027
15 June 2027

Quick facts

Lead sponsorUniversity of Oslo
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Start date15 October 2019
Primary completion15 June 2027
Estimated completion15 June 2027
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

University of Oslo

Who can join

20 and older, any sex, with Furcation Defects or Periodontal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Teeth with furcation grade III defects will be treated with open flap debridement, with or without osteoplasty. The study is designed to examine the effect of osteoplasty in the treatment of teeth with furcation grade III defects with open flap debridement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Open flap debridement with osteoplasty

Trials testing the same drug.

Other recruiting trials for Furcation Defects

Currently open trials in the same condition.

Other University of Oslo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04017429.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing